Trial
NCT03200613
Apixaban For Thromboprophylaxis In Patients With Acute Spinal Cord Injury
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
McMaster University
Collaborators
—
Condition
Spinal Cord Injuries
Intervention
Apixaban
Why stopped
study not feasible due to too slow recruitment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-02-20